Cotliar Jonathan 4
4 · Science 37 Holdings, Inc. · Filed Feb 25, 2022
Insider Transaction Report
Form 4
Cotliar Jonathan
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-10-25$0.85/sh+5,857$4,978→ 545,736 total - Exercise/Conversion
Common Stock
2021-10-28$0.40/sh+68,074$27,230→ 613,810 total - Exercise/Conversion
Common Stock
2021-12-02$0.85/sh+977$830→ 614,787 total - Exercise/Conversion
Common Stock
2021-12-02$0.40/sh+11,345$4,538→ 626,132 total - Exercise/Conversion
Stock Option
2021-10-25−4,538→ 0 totalExercise: $0.85Exp: 2027-08-01→ Common Stock (4,538 underlying) - Exercise/Conversion
Stock Option
2021-10-25−5,857→ 4,882 totalExercise: $0.85Exp: 2028-03-07→ Common Stock (5,857 underlying) - Exercise/Conversion
Stock Option
2021-10-28−68,074→ 226,920 totalExercise: $0.40Exp: 2029-06-18→ Common Stock (68,074 underlying) - Exercise/Conversion
Stock Option
2021-12-02−977→ 3,905 totalExercise: $0.85Exp: 2028-03-07→ Common Stock (977 underlying) - Exercise/Conversion
Stock Option
2021-12-02−11,345→ 215,575 totalExercise: $0.40Exp: 2029-06-18→ Common Stock (11,345 underlying) - Exercise/Conversion
Common Stock
2021-10-25$0.85/sh+4,538$3,857→ 539,879 total
Footnotes (6)
- [F1]Stock Option was fully vested and exercisable as of the date of the transaction.
- [F2]Stock Option will vest in equal monthly installments until fully vested on March 7, 2022, subject to the executive's continued service through the vesting date.
- [F3]Stock Option will vest in equal monthly installments until fully vested on June 19, 2023, subject to the executive's continued service through the applicable vesting date.
- [F4]The total amount has been adjusted to add eight derivative securities that were not previously included due to a rounding error.
- [F5]Stock Option will vest in equal monthly installments until fully vested on March 7, 2022, subject to the executive's continued service through the applicable vesting date.
- [F6]Stock Option will vest in equal monthly installments until fully vested on June 19, 2023, subject to the executive's continued service through the applicable vesting date.